Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1]
This document provides an update on a Phase 1 trial evaluating autologous CAR T cells in patients with advanced, platinum-resistant ovarian,…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)
This Clinical Trial Update documents the establishment and standardization of a platform for in-depth tumor profiling (TUPRO-Gyn) in patient…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer [Phase 2]
Phase 2 trial of HS-20089 for ovarian cancer, fallopian tube cancer, primary peritoneal cancer, and endometrial cancer is currently recruiti…
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy [NA]
The document reports a clinical trial evaluating quadratus lumborum block for postoperative pain management after cytoreductive surgery with…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod [Phase 2]
Phase 2 clinical trial evaluating a dendritic cell/tumor fusion vaccine with GM-CSF and Imiquimod for ovarian cancer, primary peritoneal can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test
A clinical trial is evaluating capillary home-sampling combined with a protein biomarker test for early detection of relapse in ovarian canc…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression [Phase 2]
A Phase 2 clinical trial update for RC48 (disitamab vedotin) in platinum-sensitive recurrent ovarian cancer expressing HER2; the study is cu…
-
CLINICAL_TRIALS research · 2019-02-01Clinical Trial Update: Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies [Phase 1]
Phase 1 clinical trial update evaluating COTI-2 as a monotherapy or in combination for multiple malignancies, sponsored by Critical Outcome …
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer
The document outlines a clinical trial evaluating the role of HE4 as a follow-up biomarker for advanced ovarian, fallopian tube, and primary…
-
CLINICAL_TRIALS research · 2018-07-11Clinical Trial Update: PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers. [Phase 1]
A Phase 1 clinical trial evaluating PD-L1 inhibition combined with focal radiotherapy in recurrent ovarian, primary peritoneal, and fallopia…
-
CLINICAL_TRIALS research · 2018-03-29Clinical Trial Update: Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer [Phase 2]
This is a Phase 2 clinical trial update for vinorelbine in relapsed platinum-resistant or refractory high-grade serous, endometrioid, or und…
-
CLINICAL_TRIALS research · 2017-05-04Clinical Trial Update: Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
This clinical trial update outlines research into the inflammatory mechanisms that occur after cytoreductive surgery with hyperthermic intra…
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Total/Subtotal Colectomy in Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating total/subtotal colectomy in ovarian cancer and related gynecologic cancers; conditions include epithelial …
-
CLINICAL_TRIALS research · 2015-06-23Clinical Trial Update: DNA Single Nucleotide Polymorphisms as Predictors of Toxicity
The document describes an ongoing clinical trial investigating whether DNA single nucleotide polymorphisms can predict treatment toxicity in…
-
CLINICAL_TRIALS research · 2015-05-06Clinical Trial Update: p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 2]
This is an update on a Phase 2 clinical trial evaluating a p53 gene therapy for recurrent ovarian epithelial cancer, fallopian tube cancer, …
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This clinical trial update covers a phase 1/2 study of combination chemotherapy with peripheral stem cell transplantation for recurrent or p…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating platinum-based chemotherapy with or without paclitaxel for relapsed ovarian cancer and primary peritonea…
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating a monoclonal antibody therapy in patients with residual disease after surgery and chemotherapy for stage I…
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer [Phase 2]
This entry reports an ongoing Phase 2 clinical trial evaluating the combination of IM-862 with chemotherapy for patients with resected stage…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
This clinical trial update describes a laboratory study aimed at predicting tumor response to chemotherapy in patients with fallopian tube c…
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating two different schedules of carboplatin, paclitaxel, and gemcitabine with surgery for newly diagnosed adv…
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer [NA]
This clinical trial update describes a study investigating whether DNA mutations can predict the effect of external-beam radiation therapy i…
-
CLINICAL_TRIALS research · 2013-08-07Clinical Trial Update: Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 2, Phase 3]
This entry describes a Phase 2/3 clinical trial evaluating combination chemotherapy with or without whole-body hyperthermia in patients with…
-
CLINICAL_TRIALS research · 2013-06-18Clinical Trial Update: Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum [Phase 2]
A Phase 2 trial evaluating the combination of bicalutamide and goserelin in ovarian cancer, fallopian tube cancer, or primary peritoneal can…
-
CLINICAL_TRIALS research · 2013-03-25Clinical Trial Update: Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
This item reports the status of a Phase 2 trial evaluating fenretinide in patients with recurrent or metastatic ovarian epithelial cancer an…